ArticleBMC chemistry2022

Design, synthesis, anticancer evaluation and docking studies of novel 2-(1-isonicotinoyl-3-phenyl-1H-pyrazol-4-yl)-3-phenylthiazolidin-4-one derivatives as Aurora-A kinase inhibitors.

Meenu Beniwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.